See also "E Swabb"
Filter your search
Click on one of these terms to refine your search
Sizes of these terms reflect their relevance to your search.
1 literature result
-
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
BACKGROUND: The amyloid-beta peptide Abeta(42) has been implicated in the pathogenesis of Alzheimer's disease (AD). We aimed to test the effects of ta…
Authors: Gordon K Wilcock, Sandra E Black, Suzanne B Hendrix, Kenton H Zavitz, Edward A Swabb, Mark A Laughlin, Tarenflurbil Phase II Study investigators
Source: Lancet neurology. 2008 Jun
View Full Text
